Seagen and Genmab Granted FDA Accelerated Approval for TIVDAK™
The U.S. FDA granted accelerated approval to Seagen Inc (SGEN) and Genmab A/S (This content is for paid subscribers.
Seagen Inc and Genmab Announce FDA Accelerated Approval for TIVDAK™ for Cervical Cancer
Today’s Highlights September 21, 2021
Today’s Highlights
September 21, 2021
